Author

Seyyedeh Azar Oliaei Motlagh

University of PennsylvaniaORCID 0000-0002-6732-8946Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cell Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1 Assay:proteomics· 1

Frequent Co-Authors

Anastasia P. VelalopoulouiD· 2 shared Constantinos KoumenisiD· 2 shared Ioannis I. VerginadisiD· 2 shared Kyle Kim· 2 shared M. E. PuttiD· 2 shared Michele M. KimiD· 2 shared Amit M. MaityiD· 1 shared Andy J. MinniD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 41 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Anastasia P. VelalopoulouORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

FLASH proton reirradiation, with or without hypofractionation, mitigates chronic toxicity in the normal murine intestine, skin, and bone.

Ioannis I. Verginadis, Anastasia P. Velalopoulou, Michele M. Kim, Kyle Kim, Ioannis Paraskevaidis, Brett Bell, Seyyedeh Azar Oliaei Motlagh, Antoneta Karaj, Esha Banerjee, Giovanni Finesso, Charles‐Antoine Assenmacher, Enrico Radaelli, Jiawei Lu, Yuewei Lin, M. E. Putt, , Theresa M. Busch

Radiotherapy and Oncology · Jan 27, 2025Peer-reviewedCell Biology

Early Inflammation and Interferon Signaling Direct Enhanced Intestinal Crypt Regeneration after Proton FLASH Radiotherapy

Tristan Lim, Clara Morral, Ioannis I. Verginadis, Kyle Kim, Leo Y. Luo, Caitlin J Foley, Michele M. Kim, Ning Li, Benjamin Yoshor, Kizito Njah, Mary Putt, Seyyedeh Azar Oliaei Motlagh, Anastasia P. Velalopoulou, Priyanka Chowdhury, Sandra Bicher, , Andy J. Minn

FLASH proton radiotherapy improves normal tissue toxicity without compromising anti-tumor efficacy by coordinating IFN-I signaling across stromal, immune, and revSC networks.

bioRxiv · Aug 16, 2024 · PreprintCell Biology